IMS to Present at UBS Global Life Sciences Conference on September 23 at 8:00 a.m. ET
NORWALK, CT, September 17, 2009 -- IMS Health (NYSE: RX), the world’s leading provider of market intelligence to the pharmaceutical and healthcare industries, today announced that Darcie Peck, vice president, Finance and Investor Relations, will present at the UBS Global Life Sciences Conference, to be held at the Grand Hyatt Hotel in New York on September 23, 2009.
To listen to a live audio Webcast of the IMS presentation on Wednesday, September 23, 2009 at 8:00 a.m. ET, go to: http://cc.talkpoint.com/ubsx001/092109a_ke/?entity=124_DT14GKJ.
A replay will be available until September 30, 2009.
Operating in more than 100 countries, IMS Health is the world’s leading provider of market intelligence to the pharmaceutical and healthcare industries. With $2.3 billion in 2008 revenue and more than 50 years of industry experience, IMS offers leading-edge market intelligence products and services that are integral to clients’ day-to-day operations, including product and portfolio management capabilities; commercial effectiveness innovations; managed care and consumer health offerings; and consulting and services solutions that improve productivity and the delivery of quality healthcare worldwide. Additional information is available at http://www.imshealth.com.